| Dr Ronald L Sagalowsky, MD | |
|
126 Middle St, Farmington, ME 04938-6937 | |
| (207) 778-4353 | |
| (207) 778-4238 |
| Full Name | Dr Ronald L Sagalowsky |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 126 Middle St, Farmington, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972540128 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | TD061040 (Maine) | Primary |
| 208800000X | Urology | 01022328A (Indiana) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald L Sagalowsky, MD 126 Middle St, Farmington, ME 04938-6937 Ph: (207) 778-4353 | Dr Ronald L Sagalowsky, MD 126 Middle St, Farmington, ME 04938-6937 Ph: (207) 778-4353 |
News Archive
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, and showed that the B cells in breast milk can generate neutralizing antibodies that may inhibit the virus that causes AIDS.
One by one, the myths of the Affordable Care Act have been revealed. When the curtain on open enrollment falls on March 31, the last remaining big myth of ObamaCare will be fully exposed: The individual mandate has failed. After a last-ditch effort with President Obama himself encouraging "young invincibles" to sign up before the deadline, the administration is scrambling to boost enrollment. On Tuesday, the White House announced that people who applied for coverage on the federal health-insurance exchange will have until mid-April to finish the paperwork (Abby McCloskey and Tom Miller, 3/26).
Merck & Co., Inc. said today that a mistrial was declared by U.S. District Court Judge John F. Keenan in Boles v. Merck, the first FOSAMAX case to go to trial. This case was the Plaintiffs' Steering Committee's first choice to take to trial. The Boles case was tried in New York federal court and involved a Florida woman who blamed her dental and jaw problems on FOSAMAX.
About 40 percent of the global population is at risk for contracting dengue - the most important mosquito-borne viral infection and a close "cousin" of the Zika virus - and yet, no effective treatment or safe licensed vaccine exists.
› Verified 5 days ago
Griffith R Batstone, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 126 Middle St, Farmington, ME 04938 Phone: 207-779-1977 Fax: 207-779-1778 |